For clinics
Patient Safety
Patient Safety
Best Lung cancer oncologists in Turkey: TOP 56 doctors
Turkey,
Istanbul
Anadolu Medical Center
accreditations:
- Specializes in lung cancer treatment, including immunotherapy, targeted therapy, and chemotherapy.
- Has experience of international practice at medical institutions in the USA, Turkey, Israel, and the UK.
- Certified by the European Society of Medical Oncology (ESMO).
- Professor at Anadolu Medical Center, with over 20 years of experience.
- Languages spoken: English, Russian (B1 level), Turkish.
All-Inclusive package price:
The doctor with the European Society of Medical Oncology accreditation. Lung cancer treatment: diagnosis + chemotherapy + immunotherapy with Keytruda
$10450
Turkey,
Istanbul
Anadolu Medical Center
Dr. Serdar Turhal is a highly experienced oncologist specializing in medical oncology and chemotherapy for breast cancer at Anadolu Medical Center. He is a member of many international oncology associations and has authored numerous articles in international publications. He specializes in prognostic factors and the therapy of malignant gastrointestinal neoplasms. To receive a consultation from Dr. Turhal, please submit a request on Bookimed.
Read more
Turkey,
Istanbul
Medipol Mega University Hospital
Dr. Ahmet Belici is an experienced medical oncologist with 20+ years of experience specializing in sarcoma and lung cancer treatments.
Read more
Turkey,
Istanbul
Medipol Mega University Hospital
Choosing Right Doctor and Clinic: Insider Tips
When selecting a doctor or clinic, keep these key points in mind:
Check credentials
Verify certifications from bodies like ISAPS, JCI, etc.
Review success rates
Choose doctors with solid experience in your specific treatment.
Read patient reviews
Browse Bookimed reviews from real patients to learn about their experiences.
Ensure effective communication
Pick clinics that offer language support for a smooth treatment process.
Ask about services
Confirm if they provide accommodation and transfers, and check the costs.
Choosing a clinic abroad can be stressful. At Bookimed, with over 800K patients helped, we understand your concerns. We know how to find trusted doctors, the best price-quality options, and solutions for even complex cases. We’re here to guide you every step of the way.
Yan Matsiivskiy
Head of Medical Coordinator Team
Turkey,
Istanbul
Anadolu Medical Center
- Dr. Bülent Karagöz specializes in lung cancer treatment, utilizing chemotherapy, radiation therapy, immunotherapy, and targeted therapies.
- He has over 20 years of experience in medical oncology, with significant expertise in tumor biology and immunology.
- Dr. Karagöz has experience of international practice at medical institutions in Turkey, NATO KFOR Command, and Turkish Cypriot Peace Forces Command.
- He holds certifications in internal medicine and medical oncology from GATA Haydarpasa Training Hospital.
- Dr. Karagöz is a member of the Turkish Medical Oncology Association and has authored over 40 publications in cancer research.
| Doctor's visit | price on request |
| CyberKnife | $8500 - $14000 |
| Da Vinci Robotic System | $18000 - $25000 |
| Radiotherapy for lung cancer | $12000 - $18000 |
Turkey,
Istanbul
Hisar Intercontinental Hospital
- Mustafa Solak, M.D., specializes in lung cancer treatment using chemotherapy, radiation therapy, and targeted therapy.
- Completed residencies at Istanbul Sisli Etfal Teaching and Research Hospital and a fellowship at Hacettepe University Cancer Institute.
- Has experience of international practice at the University of Texas MD Anderson Cancer Center, USA.
- Graduated from Hacettepe University School of Medicine, proficient in Turkish and English.
- Member of various professional organizations, including the Turkish Society of Medical Oncology.
| Doctor's visit | price on request |
| Immunotherapy with Keytruda (Pembolizumab) | $5800 - $6000 |
| Lobectomy | $9600 |
| Pneumonectomy | $11200 |
Find out about the best doctors here
20 top ranked Lung cancer doctors in the world are represented on this page. The list includes only verified specialists known for their experience and high success rates.
The ranking is composed according to the Bookimed patient reviews and considers the rating of hospitals where doctors practice.
Top 5 Lung cancer doctors on Bookimed.com:
How to choose the best Lung cancer doctors in the world?
The specialist’s CV contains details about the doctor’s expertise and work experience, education, scientific research, and languages spoken. Compare information on several specialists, read carefully about their experience, success rates, and methods they apply. Make sure the chosen doctor has relevant experience in the treatment of a medical issue you are looking for. Read reviews of patients who had a consultation with the chosen specialist.
Famous Lung cancer doctors have vast experience, continue education constantly, participate in professional associations and have positive feedback from patients treated.
What is the cost of a doctor's consultation?
The price for the consultation on Lung cancer varies between experts and depends on certain factors, such as:
- the country of practicing
- the clinical experience and reputation
- the medical degree and educational background
- the doctor’s workload
- medical developments, proprietary techniques used, and awards, if any.
How to make an appointment with a chosen doctor?
To schedule your visit, just submit a request on Bookimed.com. Our coordinator will contact you to discuss the time and details of the appointment, so everything will go smoothly.
We can help to find the right doctors for Lung cancer if you have any difficulties with a choice. Bookimed services are free for patients ♥
Where you go for medical treatment
Top 5 hospitals for Lung cancer:
Turkey,
Istanbul
Anadolu Medical Center
accreditations:
Prof. Hale Başak Çağlar is a radiation oncology director and expert in treating breast, lung, pancreatic, prostate and bone cancer. She is highly qualified, having obtained her education from Gazi University, Marmara University and Medipol University, and is a member of numerous societies, such as the American Society for Therapeutic Radiation Oncology, the European Society for Therapeutic Radiation Oncology, the European Organisation for Research and Treatment of Cancer and the Radiosurgery Society.
Read more| Doctor's visit | price on request |
| CyberKnife | $8500 - $14000 |
| Da Vinci Robotic System | $18000 - $25000 |
| Radiotherapy for lung cancer | $12000 - $18000 |
Turkey,
Istanbul
Memorial Şişli Hospital
Dr. Serkan Keskin is a highly experienced oncologist specializing in chemotherapy. He has numerous achievements in his field, including being ranked first in the Medical Oncology Proficiency Exam in Turkey in 2012. He is an active member of various prestigious oncology societies, and has a strong academic profile with 42 articles published in international journals.Read more
| Doctor's visit | price on request |
| Brachytherapy | $4800 |
| Immunotherapy with Keytruda (Pembolizumab) | $12760 |
| Lung cancer surgery | $10700 - $12500 |
Duygu Derin
Clinical oncologist
Turkey,
Istanbul
Liv Hospital Ulus
Duygu Derin
Clinical oncologist
accreditations:
Dr. Duygu Derin is an experienced medical oncologist who specializes in treating gastrointestinal cancers, lung cancer, and gynecologic neoplasms. She is a member of several oncology associations and has published more than 30 national and international scientific papers. She graduated from Galatasaray Medical High School and achieved a Medical Doctor rank from the Medical Faculty of Istanbul University. She has completed internships and professional development courses in various hospitals and holds the title of Associate Professor.
Read more
Turkey,
Istanbul
Memorial Bahçelievler Hospital
accreditations:
Prof. Sadi Kerem Okutur is a Turkish medical oncologist with over 20 years of experience. He is currently working at Memorial Bahçelievler Hospital, and has held various positions in the past. He has a degree in general medicine, and a residency in internal medicine and medical oncology. Prof. Okutur has won a research award and authored numerous papers and book chapters. He is a member of various medical societies.
Read more
Turkey,
Istanbul
Medipol Bahçelievler Hospital
Experience
2021 - 2022
Clinical Manager of Radiation Oncology, Medicana International Istanbul Hospital
2021 - 2022
Department of Radiation Oncology, Biruni University Faculty of Medicine
2020 - 2021
Clinical Manager of Radiation Oncology, Medicana International Istanbul Hospital
2017 - 2020
Clinical Manager of Radiation Oncology, Neolife Medical Center
2016 - 2017
Department of Radiation Oncology, Eskişehir Osmangazi University Faculty of Medicine
2011 - 2016
Department of Radiation Oncology, Eskişehir Osmangazi University Faculty of Medicine
2010 - 2011
Department of Radiation Oncology, Eskişehir Osmangazi University Faculty of Medicine
2008 - 2010
Radiation Oncology Clinic, Samsun Training and Research Hospital (Education Coordinator)
2006
Medical Faculty, Dokuz Eylül University
2006 - 2008
Radiation Oncology Clinic, Samsun Mehmet Aydın State Hospital (Compulsory Service)
2000 - 2006
Medical Faculty, Dokuz Eylül University
Education
2022
Biruni University Faculty of Medicine, Department of Radiation Oncology, Faculty Member, Professor Doctor
2022
Anadolu University Open Education Faculty Undergraduate Program, Cultural Heritage and Tourism
2021
Feyziye Schools Foundation Işık University Health Services Vocational School, Faculty Member, Associate Professor Doctor
2017
Eskişehir Osmangazi University Faculty of Medicine, Department of Radiation Oncology, Faculty Member
2017
Eskişehir Osmangazi University Faculty of Medicine, Department of Radiation Oncology, Associate Professor Doctor
2006
Samsun Training and Research Hospital, Specialist Doctor, Compulsory Service
2006
Dokuz Eylül University Faculty of Medicine, Department of Radiation Oncology, Medical Specialization
1998
Ege University, Faculty of Medicine
Read more
| Doctor's visit | price on request |
| Lung segmentectomy | $12000 - $15000 |
| Lobectomy | $12000 - $18000 |
| Radiotherapy for lung cancer | $4000 - $6000 |
Turkey,
Istanbul
Medipol Bahçelievler Hospital
accreditations:
PROFESSIONAL EXPERIENCE
2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine
2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine
06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine
10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship
2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship
2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist
2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.
EDUCATION
2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey
2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey
2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey
2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey
2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.
2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey
INTERNATIONAL CLINICAL TRIALS:
1. Astefania - ROCHE
- Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
- Role: Subinvestigator
2. PFİZER
- Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
- Role: Subinvestigator
3. RECITE - AMGEN
- Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
- Role: Subinvestigator
4. NAVIGATE - BAYER
- Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
- Role: Subinvestigator
5. RUBY - Tesaro (PRA)
- Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
- Role: Subinvestigator
6. ENGOT-ov43/GOG-3036 - MSD
- Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
- Role: Subinvestigator
7. ASTRA ZENECA
- Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
- Role: Subinvestigator
8. ROSY-O - ASTRA ZENECA
- Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
- Role: Subinvestigator
INTERNATIONAL PUBLICATIONS
I. Published journal articles indexed by SCI, SSCI, and AHCI
Weekly Paclitaxel in Classic Kaposi Sarcoma
- Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
- Journal: Medicine, 102(5)
Carboplatin Desensitization in Ovarian Carcinoma
- Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
- Journal: Medicine, 101(45), e31726
High-Dose Chemotherapy for Ewing’s Sarcoma
- Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
- Journal: Medicine, 101(49), e32213
Multidrug Refractory TFE3(+) Renal Cell Carcinoma
- Authors: Paksoy, Nail, et al.
- Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221
Crizotinib Efficacy in NSCLC with MET Alterations
- Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
- Journal: Medicine, 101(50), e32368
Clinicopathological Features in ALK Mutant NSCLC
- Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
- Journal: Medicine, 101(34)
PSMA-Based Tumor Burden in Prostate Cancer
- Authors: HAS SIMSEK, Duygu, et al.
- Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690
Atezolizumab in Metastatic Urothelial Carcinoma
- Authors: TURAL, Deniz, et al.
- Journal: European Urology Focus, 2021, 7.5: 1061-1066
Pulmonary Sarcomatoid Carcinoma
- Authors: FERHATOGLU, Ferhat, et al.
- Journal: Oncology Research and Treatment, 2021, 44.11: 590-601
Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma
- Authors: TURAL, Deniz, et al.
- Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513
Atezolizumab with Chemotherapy in Small Cell Lung Cancer
- Authors: GÜRBÜZ, Mustafa, et al.
- Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9
FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer
- Authors: AY, Seval, et al.
- Journal: Journal of Chemotherapy, 2022, 1-7
Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients
- Authors: CIL, Ibrahim, et al.
- Journal: Tumori Journal, 2022, 108.1: 19-25
Real-Life Efficacy of Osimertinib in Advanced NSCLC
- Authors: HIZAL, Mutlu, et al.
- Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508
ALK-Positive Cells Percentage and Alectinib Efficacy
- Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
- Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148
Real-World Data on Alectinib in ALK-Positive NSCLC
- Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
- Journal: Future Oncology, 18(23), 2573-2582
Prognostic Factors in Metastatic RCC with T790M Mutation
- Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
- Journal: Journal of Cancer Research and Therapeutics
FLOT Regimen in Metastatic Gastric Cancer
- Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
- Journal: Journal of Cancer Research and Therapeutics
Desensitization Protocol in Lenalidomide Hypersensitivity Reactions
- Authors: DEMIR, Semra, et al.
- Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397
Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity
- Authors: ÖZDEMIR, Seçil Kepil, et al.
- Journal: Allergy, 2019, 74.6: 1187-1190
Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors
- Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
- Journal: The Oncologist, oyad257
Subsequent Treatments in Hormone-Positive Breast Cancer Progression
- Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
- Journal: BMC cancer, 23(1), 192
Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer
- Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
- Journal: Scientific Reports, 13(1), 8779
Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer
- Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
- Journal: Journal of Cancer Research and Clinical Oncology, 1-9
Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer
- Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
- Journal: European Journal of Breast Health, 19(2), 128
Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer
- Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
- Journal: Future Oncology, 19(10), 727-736
Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients
- Authors: Dogan, I., Paksoy, N., & Basaran, M.
- Journal: Journal of Cancer Research and Therapeutics
Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients
- Authors: Dogan, I., Paksoy, N., & Basaran, M.
- Journal: Journal of Cancer Research and Therapeutics
Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases
- Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
- Journal: Journal of Cancer Research and Therapeutics
FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer
- Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
- Journal: Journal of Cancer Research and Therapeutics
Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer
- Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
- Journal: [Not specified]
Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma
- Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
- Journal: Medicine, 102(39), e35383
Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma
- Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
- Journal: Medicine, 102(41), e35245
Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)
Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)
Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.
Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49
Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4
Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.
Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY
Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology
Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)
Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)
Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)
Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)
Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye
Thesis:
Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)
International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)
Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination
- Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)
Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study
- Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)
Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer
- Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)
Efficacy of temozolomide in pretreated patients with metastatic sarcoma
- Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)
Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors
- Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)
Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma
- Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)
Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases
- Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)
Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma
- Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)
Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study
- Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)
Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences
- Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)
Read more
| Doctor's visit | price on request |
| Lung segmentectomy | $12000 - $15000 |
| Lobectomy | $12000 - $18000 |
| Radiotherapy for lung cancer | $4000 - $6000 |
Turkey,
Istanbul
Anadolu Medical Center
accreditations:
Prof. Şeref Kömürcü is an ECFMG and ESMO-certified medical and breast oncologist with over 20 years of experience. He specializes in solid cancer, breast cancer, colorectal and lung cancer treatment and has held teaching and scientific positions throughout his career. He is a member of several professional organizations.
Read more| Doctor's visit | price on request |
| CyberKnife | $8500 - $14000 |
| Da Vinci Robotic System | $18000 - $25000 |
| Radiotherapy for lung cancer | $12000 - $18000 |
Turkey,
Istanbul
Anadolu Medical Center
Dr. Uskent is an experienced doctor with 50+ years of practice in the field of lymphoma and other blood malfunctions. He is known for performing the first bone marrow transplant in Turkey, and has also practiced in the USA and UK.Read more
| Doctor's visit | price on request |
| CyberKnife | $8500 - $14000 |
| Da Vinci Robotic System | $18000 - $25000 |
| Radiotherapy for lung cancer | $12000 - $18000 |
Turkey,
Istanbul
Anadolu Medical Center
accreditations:
Assoc.Prof. Altan Kır is a Thoracic Surgery and Robotic Surgery specialist, as well as one of the top lung cancer doctors. He has been a thoracic surgeon at Anadolu Medical Center since 2007 and is a member of the Turkish Thoracic Surgery Society, the European Society of Thoracic Surgeons, and the Thorax Society.
Read more| Doctor's visit | price on request |
| CyberKnife | $8500 - $14000 |
| Da Vinci Robotic System | $18000 - $25000 |
| Radiotherapy for lung cancer | $12000 - $18000 |
Turkey,
Istanbul
Medipol Mega University Hospital
Professor of oncosurgery and proctology
Read more| Doctor's visit | price on request |
| Lung cancer surgery | $11500 - $14000 |
| Da Vinci Robotic System | $18000 |
| Radiotherapy for lung cancer | $8000 - $10000 |
Turkey,
Istanbul
Medical Park Göztepe Hospital Complex
Professor of Thoracic Surgery
Read more
Turkey,
Istanbul
Emsey Hospital
Dr. Lütfi Kırdar is a medical doctor with a specialization in Medical Oncology from Marmara University Faculty of Medicine, as well as a minor from Kocaeli University Faculty of Medicine. He has professional experience from Oltu State Hospital, Kocaeli State Hospital, Marmara University Pendik Training and Research Hospital, and Medistate Kavacik Hospital Medical Oncology.
Read more| Doctor's visit | price on request |
| Lung segmentectomy | $12000 - $20000 |
| Lung cancer surgery | $12500 - $24000 |
| Radiotherapy for lung cancer | $13000 - $18500 |
Turkey,
Istanbul
Emsey Hospital
Licensed Radiation Oncologist with 8 years of medical training, including undergraduate studies at Marmara University Faculty of Medicine (2004-2011) and Radiation Oncology specialization training at Marmara University Faculty of Medicine (2012-2016). Previous education from Sixteen Numbered Shirvan School (Azerbaijan) High School (1998-2004).
Read more| Doctor's visit | price on request |
| Lung segmentectomy | $12000 - $20000 |
| Lung cancer surgery | $12500 - $24000 |
| Radiotherapy for lung cancer | $13000 - $18500 |
Turkey,
Istanbul
ISU Gaziosmanpasa
Dr. Özer Akgül is an experienced Turkish Radiation Oncologist, with an MD from Uludag University Medicine School (Bursa) and residency from Ege University Hospital. He has proficiency in overseeing oncology trends, achieving set goals, understanding marketplace needs, and developing strategies. His areas of interest include breast cancer, lung cancer, prostate cancer, rectal cancer, head and neck cancers, cervical cancer, gastric cancer, and brain tumors. He has attended courses and conducted research in Nanobiotechnology, Genetics, Medical Oncology, Gynecologic Cancers, Bioinformatics, Bionanotechnological Methods, Clinical Radiobiology, Medical Radio Physics, Evidence-Based Radiation Oncology, Image-Guided Radiotherapy and Chemotherapy, Varian Advanced Techniques Clinical School, Stereotactic Radiotherapy, and Varian Advanced Imaging (IGRT). He is a member of TROD, Turkish Medical Association, MOKAD, and ESTRO.
Read more
This page may feature information relating to various medical conditions, treatments, and healthcare services available in different countries. Please be advised that the content is provided for informational purposes only and should not be construed as medical advice or guidance. Please consult with your doctor or a qualified medical professional before starting or changing medical treatment.
Related Articles
Bookimed CEO Quality Assurance